humanitarian Archived signal

Human medicines European public assessment report (EPAR): Yesafili, aflibercept, Date of authorisation: 15/09/2023, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised

Reported by EMA What Is New Oct 19, 2026 · 11:42 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Yesafili, aflibercept, Date of authorisation: 15/09/2023, Revision: 9, Status: Authorised11:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Yesafili, aflibercept, Date of authorisation: 15/09/2023, Revision: 9, Status: Authorised11:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Vgenfli, aflibercept, Date of authorisation: 14/08/2025, Revision: 1, Status: Authorised11:40 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Vgenfli, aflibercept, Date of authorisation: 14/08/2025, Revision: 1, Status: Authorised11:40 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 3, Status: Authorised11:38 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 3, Status: Authorised11:38 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Mynzepli, aflibercept, Date of authorisation: 18/08/2025, Revision: 2, Status: Authorised11:08 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Mynzepli, aflibercept, Date of authorisation: 18/08/2025, Revision: 2, Status: Authorised11:08 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Date of authorisation: 15/09/2025, Revision: 1, Status: Authorised11:05 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Eyluxvi, aflibercept, Date of authorisation: 15/09/2025, Revision: 1, Status: Authorised11:05 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 41, Status: Authorised11:02 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Eylea, aflibercept, Date of authorisation: 21/11/2012, Revision: 41, Status: Authorised11:02 UTC

INCIDENT EVOLUTION

2 recorded states

Oct 19 · 12:23 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 19 · 12:29 UTC

Headline updatedP2 · 99% quality · 2 sources

Explore this day in the archive →